论文信息 - SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay - 字舞流文

SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay

M. Peluso | Jeffrey N. Martin | T. Wrin | C. Petropoulos | T. Henrich | J. Cohen | M. Busch | B. Greenhouse | I. Rodríguez-Barraquer | S. Deeks | C. Chiu | M. Rodgers | M. Gandhi | P. Burbelo | J. Hackett | M. Stone | R. Hoh | P. Norris | Saki Takahashi | Xin X. Zhou | Cassandra Thanh | L. Torres | S. Munter | L. Trinh | Matthew A. Spinelli | A. Vallari | J. Kelly | R. Rutishauser | J. Prostko | Wesley Wu | J. Hakim | K. Turcios | J. Pak | V. Tai | E. Fehrman | Y. Hernandez | M. Spinelli | J. Wells | N. Iyer | Christopher C. Nixon | Joanna Donatelli | O. Janson | S. Elledge | Theodore Kurtz | M. Palafox | Albert Shu | C. DiGermanio | Susanna K. Elledge | Yanel Hernandez